285 related articles for article (PubMed ID: 29927011)
21. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma.
Zeng Z; Fan S; Zhang X; Li S; Zhou M; Xiong W; Tan M; Zhang W; Li G
Clin Transl Oncol; 2016 Feb; 18(2):206-11. PubMed ID: 26260913
[TBL] [Abstract][Full Text] [Related]
22. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
23. The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection.
Yang L; Liu B; Qiu F; Huang B; Li Y; Huang D; Yang R; Yang X; Deng J; Jiang Q; Zhou Y; Lu J
Carcinogenesis; 2014 Jan; 35(1):46-52. PubMed ID: 24056810
[TBL] [Abstract][Full Text] [Related]
24. Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.
Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Tsai CS; Wei YH
J Clin Oncol; 2001 May; 19(10):2607-15. PubMed ID: 11352952
[TBL] [Abstract][Full Text] [Related]
25. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
Rumayor Piña A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
[TBL] [Abstract][Full Text] [Related]
28. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
Ji MF; Sheng W; Cheng WM; Ng MH; Wu BH; Yu X; Wei KR; Li FG; Lian SF; Wang PP; Quan W; Deng L; Li XH; Liu XD; Xie YL; Huang SJ; Ge SX; Huang SL; Liang XJ; He SM; Huang HW; Xia SL; Ng PS; Chen HL; Xie SH; Liu Q; Hong MH; Ma J; Yuan Y; Xia NS; Zhang J; Cao SM
Ann Oncol; 2019 Oct; 30(10):1630-1637. PubMed ID: 31373615
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
30. Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.
Lenoci D; Resteghini C; Serafini MS; Pistore F; Canevari S; Ma B; Cavalieri S; Alfieri S; Trama A; Licitra L; De Cecco L
Transl Res; 2024 Mar; 265():1-16. PubMed ID: 37949350
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
[TBL] [Abstract][Full Text] [Related]
32. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
Chen DY; Chen YM; Lan JL; Chen HH; Hsieh CW; Wey SJ; Lu JJ
J Clin Virol; 2010 Dec; 49(4):290-5. PubMed ID: 20934910
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of plasma Epstein-Barr Virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinoma.
Chai SJ; Pua KC; Saleh A; Yap YY; Lim PV; Subramaniam SK; Lum CL; Krishnan G; Mahiyuddin WR; ; Teo SH; Khoo AS; Yap LF
J Clin Virol; 2012 Sep; 55(1):34-9. PubMed ID: 22739102
[TBL] [Abstract][Full Text] [Related]
36. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma.
Mizokami H; Okabe A; Choudhary R; Mima M; Saeda K; Fukuyo M; Rahmutulla B; Seki M; Goh BC; Kondo S; Dochi H; Moriyama-Kita M; Misawa K; Hanazawa T; Tan P; Yoshizaki T; Fullwood MJ; Kaneda A
EBioMedicine; 2024 Apr; 102():105057. PubMed ID: 38490101
[TBL] [Abstract][Full Text] [Related]
37. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
38. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY
Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996
[TBL] [Abstract][Full Text] [Related]
39. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
[TBL] [Abstract][Full Text] [Related]
40. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
